nodes	percent_of_prediction	percent_of_DWPC	metapath
Atenolol—Ibuprofen—Melphalan—peripheral nervous system neoplasm	0.352	1	CrCrCtD
Atenolol—ABCB1—peripheral nervous system neoplasm	0.342	1	CbGaD
Atenolol—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0416	0.239	CbGbCtD
Atenolol—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0416	0.239	CbGbCtD
Atenolol—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0288	0.166	CbGbCtD
Atenolol—ABCB1—Vincristine—peripheral nervous system neoplasm	0.0177	0.102	CbGbCtD
Atenolol—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.0165	0.0953	CbGbCtD
Atenolol—ABCB1—Etoposide—peripheral nervous system neoplasm	0.0163	0.0937	CbGbCtD
Atenolol—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.0111	0.0639	CbGbCtD
Atenolol—Chlorphenesin—BCHE—peripheral nervous system neoplasm	0.000849	0.501	CrCbGaD
Atenolol—Acebutolol—ABCB1—peripheral nervous system neoplasm	0.000307	0.181	CrCbGaD
Atenolol—Metoprolol—ABCB1—peripheral nervous system neoplasm	0.000259	0.153	CrCbGaD
Atenolol—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.00015	0.00115	CcSEcCtD
Atenolol—Purpura—Epirubicin—peripheral nervous system neoplasm	0.000149	0.00114	CcSEcCtD
Atenolol—Pain—Dactinomycin—peripheral nervous system neoplasm	0.000149	0.00114	CcSEcCtD
Atenolol—Ibuprofen—ABCB1—peripheral nervous system neoplasm	0.000149	0.0876	CrCbGaD
Atenolol—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000148	0.00114	CcSEcCtD
Atenolol—Vascular purpura—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.00114	CcSEcCtD
Atenolol—Anorexia—Vincristine—peripheral nervous system neoplasm	0.000148	0.00114	CcSEcCtD
Atenolol—Cardiac failure—Epirubicin—peripheral nervous system neoplasm	0.000147	0.00113	CcSEcCtD
Atenolol—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000147	0.00113	CcSEcCtD
Atenolol—Lethargy—Epirubicin—peripheral nervous system neoplasm	0.000146	0.00112	CcSEcCtD
Atenolol—Cardiac failure congestive—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.00112	CcSEcCtD
Atenolol—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.000146	0.00112	CcSEcCtD
Atenolol—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000145	0.00112	CcSEcCtD
Atenolol—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000145	0.00112	CcSEcCtD
Atenolol—Hypotension—Vincristine—peripheral nervous system neoplasm	0.000145	0.00111	CcSEcCtD
Atenolol—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.000145	0.00111	CcSEcCtD
Atenolol—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.000144	0.0011	CcSEcCtD
Atenolol—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000144	0.0011	CcSEcCtD
Atenolol—Pain in extremity—Epirubicin—peripheral nervous system neoplasm	0.000143	0.0011	CcSEcCtD
Atenolol—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.000143	0.0011	CcSEcCtD
Atenolol—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000143	0.0011	CcSEcCtD
Atenolol—Ill-defined disorder—Etoposide—peripheral nervous system neoplasm	0.000143	0.0011	CcSEcCtD
Atenolol—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.000143	0.0011	CcSEcCtD
Atenolol—Hot flush—Doxorubicin—peripheral nervous system neoplasm	0.000142	0.00109	CcSEcCtD
Atenolol—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000142	0.00109	CcSEcCtD
Atenolol—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000142	0.00109	CcSEcCtD
Atenolol—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.000141	0.00109	CcSEcCtD
Atenolol—Affect lability—Epirubicin—peripheral nervous system neoplasm	0.000141	0.00108	CcSEcCtD
Atenolol—Dermatitis exfoliative—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.00108	CcSEcCtD
Atenolol—Menopausal symptoms—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.00108	CcSEcCtD
Atenolol—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000141	0.00108	CcSEcCtD
Atenolol—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000141	0.00108	CcSEcCtD
Atenolol—Insomnia—Vincristine—peripheral nervous system neoplasm	0.00014	0.00108	CcSEcCtD
Atenolol—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.00014	0.00108	CcSEcCtD
Atenolol—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000139	0.00107	CcSEcCtD
Atenolol—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000139	0.00107	CcSEcCtD
Atenolol—Malaise—Etoposide—peripheral nervous system neoplasm	0.000139	0.00107	CcSEcCtD
Atenolol—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000139	0.00107	CcSEcCtD
Atenolol—Vertigo—Etoposide—peripheral nervous system neoplasm	0.000138	0.00106	CcSEcCtD
Atenolol—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000138	0.00106	CcSEcCtD
Atenolol—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000138	0.00106	CcSEcCtD
Atenolol—Purpura—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.00106	CcSEcCtD
Atenolol—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000137	0.00106	CcSEcCtD
Atenolol—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000137	0.00105	CcSEcCtD
Atenolol—Cardiac arrest—Epirubicin—peripheral nervous system neoplasm	0.000136	0.00105	CcSEcCtD
Atenolol—Cardiac failure—Doxorubicin—peripheral nervous system neoplasm	0.000136	0.00104	CcSEcCtD
Atenolol—Mood swings—Epirubicin—peripheral nervous system neoplasm	0.000136	0.00104	CcSEcCtD
Atenolol—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.000135	0.00104	CcSEcCtD
Atenolol—Lethargy—Doxorubicin—peripheral nervous system neoplasm	0.000135	0.00104	CcSEcCtD
Atenolol—Rash—Topotecan—peripheral nervous system neoplasm	0.000135	0.00104	CcSEcCtD
Atenolol—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000135	0.00104	CcSEcCtD
Atenolol—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000135	0.00104	CcSEcCtD
Atenolol—Ataxia—Epirubicin—peripheral nervous system neoplasm	0.000135	0.00104	CcSEcCtD
Atenolol—Cough—Etoposide—peripheral nervous system neoplasm	0.000134	0.00103	CcSEcCtD
Atenolol—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000134	0.00103	CcSEcCtD
Atenolol—Headache—Topotecan—peripheral nervous system neoplasm	0.000134	0.00103	CcSEcCtD
Atenolol—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000134	0.00103	CcSEcCtD
Atenolol—Rash—Tretinoin—peripheral nervous system neoplasm	0.000134	0.00103	CcSEcCtD
Atenolol—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000134	0.00103	CcSEcCtD
Atenolol—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000134	0.00103	CcSEcCtD
Atenolol—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000134	0.00103	CcSEcCtD
Atenolol—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000134	0.00103	CcSEcCtD
Atenolol—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000134	0.00103	CcSEcCtD
Atenolol—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000133	0.00102	CcSEcCtD
Atenolol—Headache—Tretinoin—peripheral nervous system neoplasm	0.000133	0.00102	CcSEcCtD
Atenolol—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000133	0.00102	CcSEcCtD
Atenolol—Constipation—Vincristine—peripheral nervous system neoplasm	0.000133	0.00102	CcSEcCtD
Atenolol—Pain—Vincristine—peripheral nervous system neoplasm	0.000133	0.00102	CcSEcCtD
Atenolol—Pain in extremity—Doxorubicin—peripheral nervous system neoplasm	0.000133	0.00102	CcSEcCtD
Atenolol—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000133	0.00102	CcSEcCtD
Atenolol—Rash—Melphalan—peripheral nervous system neoplasm	0.000132	0.00102	CcSEcCtD
Atenolol—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000132	0.00102	CcSEcCtD
Atenolol—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000131	0.00101	CcSEcCtD
Atenolol—Orthostatic hypotension—Epirubicin—peripheral nervous system neoplasm	0.000131	0.00101	CcSEcCtD
Atenolol—Propranolol—ABCB1—peripheral nervous system neoplasm	0.000131	0.0772	CrCbGaD
Atenolol—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000131	0.00101	CcSEcCtD
Atenolol—Affect lability—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.001	CcSEcCtD
Atenolol—Discomfort—Etoposide—peripheral nervous system neoplasm	0.00013	0.000996	CcSEcCtD
Atenolol—Aspartate aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000129	0.000992	CcSEcCtD
Atenolol—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000128	0.000986	CcSEcCtD
Atenolol—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000127	0.000979	CcSEcCtD
Atenolol—Nausea—Topotecan—peripheral nervous system neoplasm	0.000127	0.000978	CcSEcCtD
Atenolol—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000127	0.000974	CcSEcCtD
Atenolol—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000126	0.00097	CcSEcCtD
Atenolol—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000126	0.00097	CcSEcCtD
Atenolol—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.00097	CcSEcCtD
Atenolol—Mood swings—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000966	CcSEcCtD
Atenolol—Ataxia—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000959	CcSEcCtD
Atenolol—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000125	0.000958	CcSEcCtD
Atenolol—Nausea—Melphalan—peripheral nervous system neoplasm	0.000125	0.000958	CcSEcCtD
Atenolol—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000123	0.000947	CcSEcCtD
Atenolol—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000123	0.000946	CcSEcCtD
Atenolol—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000123	0.000943	CcSEcCtD
Atenolol—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000123	0.000943	CcSEcCtD
Atenolol—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000122	0.00094	CcSEcCtD
Atenolol—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000122	0.000934	CcSEcCtD
Atenolol—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000931	CcSEcCtD
Atenolol—Anorexia—Etoposide—peripheral nervous system neoplasm	0.00012	0.000921	CcSEcCtD
Atenolol—Aspartate aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.000918	CcSEcCtD
Atenolol—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000119	0.000917	CcSEcCtD
Atenolol—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000119	0.000913	CcSEcCtD
Atenolol—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000118	0.000911	CcSEcCtD
Atenolol—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000117	0.000903	CcSEcCtD
Atenolol—Pain—Cisplatin—peripheral nervous system neoplasm	0.000117	0.000902	CcSEcCtD
Atenolol—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000116	0.000888	CcSEcCtD
Atenolol—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000114	0.000876	CcSEcCtD
Atenolol—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000113	0.000869	CcSEcCtD
Atenolol—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000113	0.000868	CcSEcCtD
Atenolol—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000112	0.000861	CcSEcCtD
Atenolol—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000112	0.000859	CcSEcCtD
Atenolol—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000111	0.000856	CcSEcCtD
Atenolol—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000111	0.000849	CcSEcCtD
Atenolol—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.00011	0.000847	CcSEcCtD
Atenolol—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00011	0.000842	CcSEcCtD
Atenolol—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000109	0.00084	CcSEcCtD
Atenolol—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000109	0.000835	CcSEcCtD
Atenolol—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000109	0.000834	CcSEcCtD
Atenolol—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000108	0.000834	CcSEcCtD
Atenolol—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000108	0.000833	CcSEcCtD
Atenolol—Pain—Etoposide—peripheral nervous system neoplasm	0.000108	0.000826	CcSEcCtD
Atenolol—Constipation—Etoposide—peripheral nervous system neoplasm	0.000108	0.000826	CcSEcCtD
Atenolol—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000107	0.000819	CcSEcCtD
Atenolol—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000106	0.000816	CcSEcCtD
Atenolol—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000814	CcSEcCtD
Atenolol—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000801	CcSEcCtD
Atenolol—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000104	0.000796	CcSEcCtD
Atenolol—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000103	0.000793	CcSEcCtD
Atenolol—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000793	CcSEcCtD
Atenolol—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000103	0.000789	CcSEcCtD
Atenolol—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000102	0.000786	CcSEcCtD
Atenolol—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000102	0.00078	CcSEcCtD
Atenolol—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000101	0.00078	CcSEcCtD
Atenolol—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000101	0.000776	CcSEcCtD
Atenolol—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000101	0.000775	CcSEcCtD
Atenolol—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000772	CcSEcCtD
Atenolol—Body temperature increased—Etoposide—peripheral nervous system neoplasm	9.94e-05	0.000764	CcSEcCtD
Atenolol—Asthenia—Cisplatin—peripheral nervous system neoplasm	9.85e-05	0.000757	CcSEcCtD
Atenolol—Sweating—Doxorubicin—peripheral nervous system neoplasm	9.8e-05	0.000753	CcSEcCtD
Atenolol—Rash—Vincristine—peripheral nervous system neoplasm	9.79e-05	0.000752	CcSEcCtD
Atenolol—Dermatitis—Vincristine—peripheral nervous system neoplasm	9.78e-05	0.000751	CcSEcCtD
Atenolol—Headache—Vincristine—peripheral nervous system neoplasm	9.72e-05	0.000747	CcSEcCtD
Atenolol—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	9.64e-05	0.000741	CcSEcCtD
Atenolol—Nausea—Alitretinoin—peripheral nervous system neoplasm	9.57e-05	0.000735	CcSEcCtD
Atenolol—Visual impairment—Epirubicin—peripheral nervous system neoplasm	9.56e-05	0.000735	CcSEcCtD
Atenolol—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	9.54e-05	0.000733	CcSEcCtD
Atenolol—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	9.39e-05	0.000722	CcSEcCtD
Atenolol—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	9.34e-05	0.000718	CcSEcCtD
Atenolol—Tinnitus—Epirubicin—peripheral nervous system neoplasm	9.25e-05	0.000711	CcSEcCtD
Atenolol—Nausea—Vincristine—peripheral nervous system neoplasm	9.22e-05	0.000708	CcSEcCtD
Atenolol—Flushing—Epirubicin—peripheral nervous system neoplasm	9.21e-05	0.000708	CcSEcCtD
Atenolol—Asthenia—Etoposide—peripheral nervous system neoplasm	9.02e-05	0.000693	CcSEcCtD
Atenolol—Pruritus—Etoposide—peripheral nervous system neoplasm	8.9e-05	0.000684	CcSEcCtD
Atenolol—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	8.86e-05	0.000681	CcSEcCtD
Atenolol—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	8.85e-05	0.00068	CcSEcCtD
Atenolol—Alopecia—Epirubicin—peripheral nervous system neoplasm	8.77e-05	0.000674	CcSEcCtD
Atenolol—Rash—Cisplatin—peripheral nervous system neoplasm	8.65e-05	0.000665	CcSEcCtD
Atenolol—Dermatitis—Cisplatin—peripheral nervous system neoplasm	8.65e-05	0.000664	CcSEcCtD
Atenolol—Diarrhoea—Etoposide—peripheral nervous system neoplasm	8.6e-05	0.000661	CcSEcCtD
Atenolol—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	8.56e-05	0.000658	CcSEcCtD
Atenolol—Flushing—Doxorubicin—peripheral nervous system neoplasm	8.52e-05	0.000655	CcSEcCtD
Atenolol—Tension—Epirubicin—peripheral nervous system neoplasm	8.47e-05	0.000651	CcSEcCtD
Atenolol—Nervousness—Epirubicin—peripheral nervous system neoplasm	8.39e-05	0.000645	CcSEcCtD
Atenolol—Dizziness—Etoposide—peripheral nervous system neoplasm	8.31e-05	0.000639	CcSEcCtD
Atenolol—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	8.2e-05	0.00063	CcSEcCtD
Atenolol—Nausea—Cisplatin—peripheral nervous system neoplasm	8.15e-05	0.000626	CcSEcCtD
Atenolol—Vision blurred—Epirubicin—peripheral nervous system neoplasm	8.14e-05	0.000625	CcSEcCtD
Atenolol—Alopecia—Doxorubicin—peripheral nervous system neoplasm	8.11e-05	0.000623	CcSEcCtD
Atenolol—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	8.01e-05	0.000616	CcSEcCtD
Atenolol—Rash—Etoposide—peripheral nervous system neoplasm	7.93e-05	0.000609	CcSEcCtD
Atenolol—Dermatitis—Etoposide—peripheral nervous system neoplasm	7.92e-05	0.000609	CcSEcCtD
Atenolol—Headache—Etoposide—peripheral nervous system neoplasm	7.88e-05	0.000605	CcSEcCtD
Atenolol—Tension—Doxorubicin—peripheral nervous system neoplasm	7.84e-05	0.000603	CcSEcCtD
Atenolol—Malaise—Epirubicin—peripheral nervous system neoplasm	7.79e-05	0.000598	CcSEcCtD
Atenolol—Nervousness—Doxorubicin—peripheral nervous system neoplasm	7.76e-05	0.000596	CcSEcCtD
Atenolol—Vertigo—Epirubicin—peripheral nervous system neoplasm	7.76e-05	0.000596	CcSEcCtD
Atenolol—Syncope—Epirubicin—peripheral nervous system neoplasm	7.74e-05	0.000595	CcSEcCtD
Atenolol—Palpitations—Epirubicin—peripheral nervous system neoplasm	7.63e-05	0.000586	CcSEcCtD
Atenolol—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	7.59e-05	0.000583	CcSEcCtD
Atenolol—Cough—Epirubicin—peripheral nervous system neoplasm	7.54e-05	0.000579	CcSEcCtD
Atenolol—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	7.53e-05	0.000579	CcSEcCtD
Atenolol—Nausea—Etoposide—peripheral nervous system neoplasm	7.47e-05	0.000574	CcSEcCtD
Atenolol—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	7.41e-05	0.00057	CcSEcCtD
Atenolol—Chest pain—Epirubicin—peripheral nervous system neoplasm	7.35e-05	0.000565	CcSEcCtD
Atenolol—Anxiety—Epirubicin—peripheral nervous system neoplasm	7.33e-05	0.000563	CcSEcCtD
Atenolol—Discomfort—Epirubicin—peripheral nervous system neoplasm	7.26e-05	0.000558	CcSEcCtD
Atenolol—Malaise—Doxorubicin—peripheral nervous system neoplasm	7.21e-05	0.000554	CcSEcCtD
Atenolol—Dry mouth—Epirubicin—peripheral nervous system neoplasm	7.19e-05	0.000553	CcSEcCtD
Atenolol—Vertigo—Doxorubicin—peripheral nervous system neoplasm	7.18e-05	0.000552	CcSEcCtD
Atenolol—Syncope—Doxorubicin—peripheral nervous system neoplasm	7.17e-05	0.000551	CcSEcCtD
Atenolol—Confusional state—Epirubicin—peripheral nervous system neoplasm	7.11e-05	0.000546	CcSEcCtD
Atenolol—Palpitations—Doxorubicin—peripheral nervous system neoplasm	7.06e-05	0.000543	CcSEcCtD
Atenolol—Oedema—Epirubicin—peripheral nervous system neoplasm	7.05e-05	0.000542	CcSEcCtD
Atenolol—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	7.02e-05	0.00054	CcSEcCtD
Atenolol—Cough—Doxorubicin—peripheral nervous system neoplasm	6.97e-05	0.000536	CcSEcCtD
Atenolol—Shock—Epirubicin—peripheral nervous system neoplasm	6.93e-05	0.000533	CcSEcCtD
Atenolol—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	6.9e-05	0.00053	CcSEcCtD
Atenolol—Tachycardia—Epirubicin—peripheral nervous system neoplasm	6.88e-05	0.000529	CcSEcCtD
Atenolol—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	6.81e-05	0.000524	CcSEcCtD
Atenolol—Chest pain—Doxorubicin—peripheral nervous system neoplasm	6.8e-05	0.000523	CcSEcCtD
Atenolol—Anxiety—Doxorubicin—peripheral nervous system neoplasm	6.78e-05	0.000521	CcSEcCtD
Atenolol—Discomfort—Doxorubicin—peripheral nervous system neoplasm	6.72e-05	0.000517	CcSEcCtD
Atenolol—Anorexia—Epirubicin—peripheral nervous system neoplasm	6.72e-05	0.000516	CcSEcCtD
Atenolol—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	6.65e-05	0.000511	CcSEcCtD
Atenolol—Hypotension—Epirubicin—peripheral nervous system neoplasm	6.59e-05	0.000506	CcSEcCtD
Atenolol—Confusional state—Doxorubicin—peripheral nervous system neoplasm	6.58e-05	0.000505	CcSEcCtD
Atenolol—Oedema—Doxorubicin—peripheral nervous system neoplasm	6.52e-05	0.000501	CcSEcCtD
Atenolol—Shock—Doxorubicin—peripheral nervous system neoplasm	6.42e-05	0.000493	CcSEcCtD
Atenolol—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	6.39e-05	0.000491	CcSEcCtD
Atenolol—Insomnia—Epirubicin—peripheral nervous system neoplasm	6.37e-05	0.00049	CcSEcCtD
Atenolol—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	6.36e-05	0.000489	CcSEcCtD
Atenolol—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	6.33e-05	0.000486	CcSEcCtD
Atenolol—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	6.3e-05	0.000484	CcSEcCtD
Atenolol—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	6.28e-05	0.000483	CcSEcCtD
Atenolol—Somnolence—Epirubicin—peripheral nervous system neoplasm	6.27e-05	0.000482	CcSEcCtD
Atenolol—Anorexia—Doxorubicin—peripheral nervous system neoplasm	6.22e-05	0.000478	CcSEcCtD
Atenolol—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	6.2e-05	0.000477	CcSEcCtD
Atenolol—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	6.13e-05	0.000471	CcSEcCtD
Atenolol—Hypotension—Doxorubicin—peripheral nervous system neoplasm	6.09e-05	0.000468	CcSEcCtD
Atenolol—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	6.08e-05	0.000468	CcSEcCtD
Atenolol—Fatigue—Epirubicin—peripheral nervous system neoplasm	6.08e-05	0.000467	CcSEcCtD
Atenolol—Pain—Epirubicin—peripheral nervous system neoplasm	6.03e-05	0.000463	CcSEcCtD
Atenolol—Constipation—Epirubicin—peripheral nervous system neoplasm	6.03e-05	0.000463	CcSEcCtD
Atenolol—Insomnia—Doxorubicin—peripheral nervous system neoplasm	5.9e-05	0.000453	CcSEcCtD
Atenolol—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	5.86e-05	0.00045	CcSEcCtD
Atenolol—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	5.81e-05	0.000447	CcSEcCtD
Atenolol—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	5.81e-05	0.000446	CcSEcCtD
Atenolol—Somnolence—Doxorubicin—peripheral nervous system neoplasm	5.8e-05	0.000446	CcSEcCtD
Atenolol—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	5.74e-05	0.000441	CcSEcCtD
Atenolol—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	5.67e-05	0.000436	CcSEcCtD
Atenolol—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	5.63e-05	0.000433	CcSEcCtD
Atenolol—Fatigue—Doxorubicin—peripheral nervous system neoplasm	5.62e-05	0.000432	CcSEcCtD
Atenolol—Pain—Doxorubicin—peripheral nervous system neoplasm	5.58e-05	0.000429	CcSEcCtD
Atenolol—Constipation—Doxorubicin—peripheral nervous system neoplasm	5.58e-05	0.000429	CcSEcCtD
Atenolol—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	5.57e-05	0.000428	CcSEcCtD
Atenolol—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	5.37e-05	0.000413	CcSEcCtD
Atenolol—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	5.16e-05	0.000396	CcSEcCtD
Atenolol—Asthenia—Epirubicin—peripheral nervous system neoplasm	5.06e-05	0.000389	CcSEcCtD
Atenolol—Pruritus—Epirubicin—peripheral nervous system neoplasm	4.99e-05	0.000383	CcSEcCtD
Atenolol—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	4.82e-05	0.000371	CcSEcCtD
Atenolol—Asthenia—Doxorubicin—peripheral nervous system neoplasm	4.68e-05	0.00036	CcSEcCtD
Atenolol—Dizziness—Epirubicin—peripheral nervous system neoplasm	4.66e-05	0.000358	CcSEcCtD
Atenolol—Pruritus—Doxorubicin—peripheral nervous system neoplasm	4.61e-05	0.000355	CcSEcCtD
Atenolol—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	4.46e-05	0.000343	CcSEcCtD
Atenolol—Rash—Epirubicin—peripheral nervous system neoplasm	4.44e-05	0.000342	CcSEcCtD
Atenolol—Dermatitis—Epirubicin—peripheral nervous system neoplasm	4.44e-05	0.000341	CcSEcCtD
Atenolol—Headache—Epirubicin—peripheral nervous system neoplasm	4.42e-05	0.000339	CcSEcCtD
Atenolol—Dizziness—Doxorubicin—peripheral nervous system neoplasm	4.31e-05	0.000331	CcSEcCtD
Atenolol—Nausea—Epirubicin—peripheral nervous system neoplasm	4.19e-05	0.000322	CcSEcCtD
Atenolol—Rash—Doxorubicin—peripheral nervous system neoplasm	4.11e-05	0.000316	CcSEcCtD
Atenolol—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	4.11e-05	0.000316	CcSEcCtD
Atenolol—Headache—Doxorubicin—peripheral nervous system neoplasm	4.09e-05	0.000314	CcSEcCtD
Atenolol—Nausea—Doxorubicin—peripheral nervous system neoplasm	3.87e-05	0.000298	CcSEcCtD
